logo
Google CEO adds a new calendar feature at Stripe co-founder's request

Google CEO adds a new calendar feature at Stripe co-founder's request

Yahoo2 days ago
Talk about customer service. On Wednesday, Google CEO Sundar Pichai posted on X about Google Calendar's new feature to duplicate events — an addition that was specifically requested by Stripe co-founder John Collison last month, also via an X post.
On July 5, Collison asked if Google Calendar users could get a Ctrl-click option that would allow them to easily duplicate events, similar to the feature that many native calendar applications already have. Collison tagged Pichai in his post at the time.
While users often tag companies and CEOs with online feedback and complaints, you know you've made it when the CEO not only replies to you, but also implements the change you've asked for.
That's the case for Collison, at least.
Wrote Pichai, 'This feature is now live for everyone on Google Calendar on the web — thanks for the suggestion!'
Naturally, some X users began to poke fun at Collison's seeming influence by asking him to help with their own specific concerns, too.
Joked Box CEO Aaron Levie, for example, referring to the notoriously congested highway that runs through Silicon Valley, where Waymo's self-driving cars currently have limited availability, 'John, can you ask Waymo to work on El Camino through the peninsula? Thanks!'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Medical Tubing Market worth $18.41 billion by 2030, at a CAGR of 8.0%, says MarketsandMarkets™
Medical Tubing Market worth $18.41 billion by 2030, at a CAGR of 8.0%, says MarketsandMarkets™

Yahoo

timea minute ago

  • Yahoo

Medical Tubing Market worth $18.41 billion by 2030, at a CAGR of 8.0%, says MarketsandMarkets™

Delray Beach, FL, Aug. 15, 2025 (GLOBE NEWSWIRE) -- The Medical Tubing Market is projected to reach USD 18.41 billion by 2030 from USD 12.53 billion in 2025, at a CAGR of 8.0% during the forecast period. The market for medical tubing is expanding swiftly due to growing worldwide geriatric population, susceptible to chronic conditions such as cardiovascular disorders and kidney failure, propelling demand for medical tubing across markets like catheters, dialysis, and fluid management. Further, growing popularity for less invasive treatments like endoscopy and angioplasty, with their need for flexible and strong tubing, is propelling market growth. Technological advances in extrusion provide high-quality tubing with improved kink resistance, tensile strength, and flexibility. Breakthroughs in material technology, e.g., silicone, polyurethane, and thermoplastic elastomers, enable enhanced performance for numerous applications including drug delivery and respiratory treatment. Additionally, growth in emerging markets in healthcare infrastructure, higher spending on healthcare, and a move towards home healthcare—where light tubing is needed by portable medical devices—helps to fuel the market. The cumulative effect of population aging, the need for minimally invasive surgery, advances in technology, and compliance with regulations helps maintain a growth momentum in the medical tubing market as evolving global healthcare demands persist. Download PDF Brochure: Browse in-depth TOC on 'Medical Tubing Market' 238 - Market Data Tables 53 – Figures 252 - Pages List of Key Players in Medical Tubing Market: Saint-Gobain (France) Freudenberg Medical (US) W. L. Gore & Associates, Inc. (US) The Lubrizol Corporation (US) Nordson Corporation (US) TE Connectivity (Switzerland) Elkem ASA (Norway) Trelleborg AB (Sweden) RAUMEDIC AG (Germany) Teknor Apex (US) Spectrum Plastics Group (US) Zeus Company LLC (US) Drivers, Opportunities and Challenges in Medical Tubing Market: Drivers: Increasing demand for minimally invasive medical procedures Restraint: Limited material compatibility Opportunity: Increasing governmental expenditure for upgrading and developing healthcare infrastructure Challenge: High cost of producing and marketing medical tubing products Get Sample Pages: Key Findings of the Study: Rubber has the largest market share in the medical tubing market during the forecast period. Catheters & cannulas holds the largest share in the medical tubing market during forecast period. In terms of structure, multi-lumen holds the largest share in the medical tubing market during forecast period. North America to be the largest market during the forecast period. Smart tubing in healthcare application are the new advanced tubing systems that have sensors, conductive components, or microfluidic channels integrated into them for enhanced functionality, security, and monitoring. Such tubes are beyond the mere transportation of fluid as they consist of real-time data collection, automation, and enhanced control features, which provide better patient care and procedural efficiency. One of the important features of smart tubing is intrinsic sensors that track parameters such as pressure, temperature, and flow rate to achieve optimal performance in applications like intravenous (IV) therapy, dialysis, and catheterization. Real-time monitoring ensures detection of blockages, leaks, or aberrations, minimizing complications. Certain smart tubing systems also feature RFID or Bluetooth technology for wireless data communication, facilitating remote monitoring in hospital and home healthcare environments. Specialty polymers are growing fastest in the medical tubing market due to their exceptional performance properties, which address the changing demands of the healthcare market. These include thermoplastic elastomers (TPE), polyether ether ketone (PEEK), and fluoropolymers. They provide increased biocompatibility, chemical resistance, and abrasion resistance compared to traditional rubbers and plastics. Their resistance to aggressive sterilization methods, such as autoclaving and gamma radiation, also makes them suitable for use in applications that demand high standards of hygiene, e.g., catheters, intravenous (IV) tubing, and dialysis machines. The increasing demand for minimally invasive surgical procedures has also promoted the use of specialty polymers, as they allow for the creation of flexible, lightweight, and high-performance tubing. Their greater mechanical toughness ensures consistency in rigorous applications, reducing the risk of tube collapse and enhancing patient safety. Specialty polymers are also more resistant to drug interaction and biofouling, ensuring medical liquid integrity as it flows through the tubing. The increasing cases of chronic diseases, such as cardiovascular diseases and diabetes, are propelling higher demand for more advanced medical equipment, hence driving demand for specialty polymer tubing. The fast-paced progress in the field of material science has made it possible to design antimicrobial polymers, thus improving infection prevention in medical facilities. Regulatory bodies like the FDA and EU MDR have also mandated strict standards for medical materials, with a preference for high-performance polymers that are safe and sustainable. As medical device companies and healthcare providers look for materials with better functionality, durability, and regulatory compliance, specialty polymers continue to see accelerated uptake. Their distinct benefits over conventional materials, along with the increasing focus on innovation and patient-centered care, are propelling their highest growth in the medical tubing industry. Drug delivery systems are witnessing the most rapid expansion in the medical tubing industry due to changing healthcare requirements and technological innovation. The increasing incidence of chronic diseases requires effective and targeted drug delivery. Tubing is essential to these systems, allowing drug delivery directly to targeted locations within the body for increased efficacy with reduced side effects. This requirement is further fuelled by the aging population globally, which increasingly needs frequent and advanced medical therapy, much of which involves the use of drug-delivery tubing. In addition, ever-present innovation in drug delivery technology is a key driver. Breakthroughs such as injectable systems, insulin pumps, and inhalers are highly dependent on tailor-made medical tubing to operate efficiently. The evolution of minimally invasive drug delivery systems, including microneedle arrays or linked drug delivery devices, has boosted demand for specialized tubing that can meet complex specifications such as controlled release or high-viscosity biologics. Such innovations enhance patient compliance and comfort, further enhancing adoption. The trend towards personalized medicine drives this growth. Personalized treatments need flexible tubing solutions that can support customized drug formulations and delivery regimens, so drug delivery systems are a dynamic category. Partnerships between medical device and pharma companies are broadening the scope and application of these systems, fueling demand for premium, biocompatible tubing materials such as silicone and fluoropolymers. Get Customization on this Report: The medical tubing market offers various growth opportunities spurred by advances in healthcare technologies, surging demand for minimally invasive procedures, and the high incidence of chronic diseases. The greatest opportunity comes in the increasing usage of home healthcare and wearable medical devices like insulin pumps and portable oxygen therapy that need top-grade, flexible, and robust tubing. Moreover, the growing application of biologics generate a need for specialized tubing solutions that provide the safe and accurate delivery of sensitive drugs. Advances in material science, such as biodegradable and antimicrobial tubing, provide opportunities to improve patient safety and minimize hospital-acquired infections. The incorporation of intelligent technologies, including sensors on tubing for the real-time measurement of fluid flow and pressure, is another area with great promise, enhancing the accuracy and efficiency of treatment. Asian-Pacific and Latin America provide compelling opportunities for growth that are accompanied by building up health care infrastructures and further investments by the governments in the manufacture of medical devices. Additionally, the movement toward green and recyclable medical materials concurs with world environmental campaigns to support the design of green medical tubing. With ongoing needs for healthcare, on-going research and advancements in technology will create increased prospects for the medical tubing market. Saint-Gobain (France) is a French multinational corporation dedicated to industrial construction materials and services manufacturing and distribution. The medical tubing business segment operates under its subsidiary Saint-Gobain Performance Plastics which trades as Saint-Gobain Life Sciences. The division of Saint-Gobain Performance Plastics develops numerous high-performance materials and component products including medical tubing products for medical applications in healthcare sectors. Freudenberg Medical (US), a division of Germany-based Freudenberg Group, develops medical components and devices while also designing and manufacturing them. By operating under Freudenberg Group's specialties business area the company delivers catheters, hypotubes and balloons with minimally invasive procedure coating solutions alongside steerable shafts, engineered needles and precision-molded components and medical silicone and plastic tubing. Freudenberg Medical operates 11 manufacturing facilities through corporate branches located across the Americas, Europe and Asia servicing Costa Rica, India, China, Ireland, Singapore, the United States and Germany. Browse Adjacent Markets Specialty Chemicals Market Research Reports & Consulting Related Reports: Chillers Market Lubricants Market Global Chemical Industry Outlook 2025 Wood Coatings Market Cooling Fabrics Market CONTACT: About MarketsandMarkets™ MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit or follow us on Twitter, LinkedIn and Facebook. Contact: Mr. Rohan Salgarkar MarketsandMarkets™ INC. 1615 South Congress Ave. Suite 103, Delray Beach, FL 33445, USA: +1-888-600-6441 Email: sales@ Visit Our Website: in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

RocketBarn Marketing Named 2025 FBR Employee Satisfaction Award Finalist for Second Consecutive Year by Franchise Business Review
RocketBarn Marketing Named 2025 FBR Employee Satisfaction Award Finalist for Second Consecutive Year by Franchise Business Review

Yahoo

timea minute ago

  • Yahoo

RocketBarn Marketing Named 2025 FBR Employee Satisfaction Award Finalist for Second Consecutive Year by Franchise Business Review

Independent Survey Recognizes RocketBarn Marketing for Outstanding Company Culture and Employee Satisfaction in the Franchise Sector Nashville, Tennessee--(Newsfile Corp. - August 15, 2025) - RocketBarn Marketing was just named a finalist for the 2025 Employee Satisfaction Awards by Franchise Business Review for the second consecutive year. The awards recognize franchise companies with the highest employee satisfaction based on an independent survey of their employees. To view an enhanced version of this graphic, please visit: RocketBarn is a specialized digital marketing agency for franchises, helping multi-location brands grow through data-driven, locally focused campaigns. As a distinguished 2025 Google Premier Partner and active member of both the International Franchise Association and Canadian Franchise Association, RocketBarn delivers core services including Google Search advertising, social media ads, programmatic campaigns, and organic SEO strategies-tailored for both the corporate franchisor and local franchisee business levels. Franchise Business Review (FBR), a market research firm that specializes in benchmarking satisfaction within the franchising sector, conducts surveys of corporate franchise employees, franchise supplier employees, and franchise owners' employees across North America to determine their levels of engagement of job satisfaction. FBR's Employee Engagement research helps franchise companies understand how their organizational culture and engagement compares to other companies in the franchise sector and improve hiring and retention practices. Participants are asked questions related to job satisfaction, engagement, skills and experience, management, brand leadership, and collective results are released annually in FBR's Franchising at WORK Report. Franchise companies that participated in FBR's Employee Engagement research were eligible for the Employee Satisfaction Awards. FBR analyzed data from over 11,000 corporate and unit-level employees to identify the finalists. "FBR's Employee Satisfaction Awards are the only awards that shine a light on the franchise companies truly committed to putting their employees first," said Michelle Rowan, president & COO of Franchise Business Review. "In a time when attracting and keeping great talent is essential to a company's success, we're proud to celebrate these standout brands for creating positive, people-focused cultures where employee feedback is valued and teams are actively involved in building that success." Matt Martin, CEO & Founder of RocketBarn, remarked, "It's an incredible honor to be recognized for the second year in a row among such an inspiring community of franchise businesses. At RocketBarn, we're deeply committed to putting people and relationships at the heart of everything we do-both in our team culture and in how we partner with our marketing clients. After reviewing last year's employee survey results, we made a focused effort to elevate the team experience even further. Being named a finalist again this year is a strong signal that our commitment is making a meaningful impact. A heartfelt thank you to FBR for providing such a valuable platform to measure, support, and celebrate healthy workplaces in franchising." Winners will be announced live on August 20, 2025 at 2:00 pm ET. To learn more about FBR's Employee Satisfaction Awards, visit About RocketBarn Marketing RocketBarn partners with franchise systems to engage franchisees in local digital marketing efforts that drive measurable growth within their businesses. RocketBarn's services include Google Ads, Performance Max, Facebook and Instagram advertising, programmatic media, and local SEO, strategically built to support both corporate franchisor marketing goals and local franchisee success. Every client is supported by a dedicated Franchise Marketing Advisor who ensures your campaigns are aligned, optimized, and built for long-term growth. About Franchise Business Review Franchise Business Review (FBR) is a leading independent market research firm that provides franchise organizations with benchmarking research and best practices to improve franchisee and employee satisfaction and engagement. Since 2005, FBR has been trusted by more than 1,300 top-performing franchise companies to equip them with the people-centric data, insights, and tools they need for long-term growth and success in the franchise industry. Learn more about how FBR helps franchise companies at Name: Alex PreddieCompany: RocketBarn MarketingEmail: alex@ To view the source version of this press release, please visit Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

2 Big Reasons the 2026 Social Security COLA Might Not Be Enough
2 Big Reasons the 2026 Social Security COLA Might Not Be Enough

Yahoo

timea minute ago

  • Yahoo

2 Big Reasons the 2026 Social Security COLA Might Not Be Enough

Key Points The latest estimates call for a 2026 COLA of 2.7%, although we won't know for sure until October. The inflation metric used to calculate the COLA isn't doing a great job of tracking expenses on older Americans. Medicare Part B premium increases could consume a large portion of the COLA. The $23,760 Social Security bonus most retirees completely overlook › After the July inflation data was released, the latest estimates from the Senior Citizens League are calling for a Social Security cost-of-living adjustment, or COLA, of 2.7% for beneficiaries in 2026. This is one-tenth of one percentage point greater than the prior estimate and would be a raise from the 2.5% COLA that went into effect this year. Social Security COLAs help retirees and other beneficiaries keep up with the rising costs of goods and services. And while a higher estimated COLA might sound like good news, there are a couple of good reasons it might not be enough. Here's what all retirees and other Social Security beneficiaries should know. Medicare premiums could consume a lot of the COLA The first reason the 2026 COLA might not be enough is Medicare premiums. Specifically, Social Security beneficiaries who are over 65 and enrolled in Medicare typically pay their Medicare Part B premiums directly from their Social Security checks. Here's the key point. Although the COLA is expected to add 2.7% to Social Security benefits, Medicare Part B premiums are expected to rise by 11.6%, from $185 per month this year to $206.50 per month in 2026. The average retired worker would get a $54 monthly increase from a 2.7% COLA. However, $21.50 of this would be consumed by Medicare premium increases. This would make the effective increase $33.50 per month that can be used to help pay for living expenses. This isn't exactly a unique occurrence for 2026. Over the past five years, Social Security COLAs have produced a cumulative increase of about 23% for beneficiaries. In the same period, Medicare Part B premiums have risen by 28%, consuming more and more of the Social Security checks of Medicare beneficiaries. The CPI-W isn't the best inflation metric for the elderly When calculating the Social Security COLA, the inflation metric that is used is a variation of the consumer price index called the CPI-W. This increased by 2.5% year over year in July and is intended to measure inflation as it affects workers. This creates an obvious issue -- most Social Security beneficiaries are retired, and different goods and services affect them differently. There's another metric called the CPI-E that is specifically designed to measure the effects of inflation on the elderly. Just to name a couple examples, seniors tend to spend a greater portion of their income on healthcare and housing than the average American household. In July, the year-over-year inflation rate for outpatient hospital services was 6.4%. Housing costs have increased by 3.7% over the past year. Overall, the CPI-E increased by 2.9% year over year in July, 0.4% more than the CPI-W. When will we know the 2026 Social Security COLA for sure? As it stands, because of a combination of expected Medicare premium increases and senior-specific costs rising faster than the Social Security Administration's preferred inflation metric, the COLA might not do its intended job of helping seniors keep up with the cost of living. As a final point, it's important to realize that we don't know for sure what the COLA will be for 2026. It's based on third-quarter CPI-W data (July, August, and September), and we've only seen one of those monthly reports so far. We'll know for sure how much of a raise seniors will get when finalized third quarter inflation data is available in mid-October. The $23,760 Social Security bonus most retirees completely overlook If you're like most Americans, you're a few years (or more) behind on your retirement savings. But a handful of little-known could help ensure a boost in your retirement income. One easy trick could pay you as much as $23,760 more... each year! Once you learn how to maximize your Social Security benefits, we think you could retire confidently with the peace of mind we're all after. Join Stock Advisor to learn more about these Motley Fool has a disclosure policy. 2 Big Reasons the 2026 Social Security COLA Might Not Be Enough was originally published by The Motley Fool Melden Sie sich an, um Ihr Portfolio aufzurufen.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store